150 related articles for article (PubMed ID: 11893779)
1. In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice.
Furbee JW; Francone O; Parks JS
J Lipid Res; 2002 Mar; 43(3):428-37. PubMed ID: 11893779
[TBL] [Abstract][Full Text] [Related]
2. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
Furbee JW; Sawyer JK; Parks JS
J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
[TBL] [Abstract][Full Text] [Related]
3. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins.
Zhao Y; Thorngate FE; Weisgraber KH; Williams DL; Parks JS
Biochemistry; 2005 Jan; 44(3):1013-25. PubMed ID: 15654758
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
Furbee JW; Parks JS
Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
[TBL] [Abstract][Full Text] [Related]
6. Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans.
Pavanello C; Ossoli A; Strazzella A; Risè P; Veglia F; Lhomme M; Parini P; Calabresi L
J Lipid Res; 2022 Jul; 63(7):100232. PubMed ID: 35598637
[TBL] [Abstract][Full Text] [Related]
7. Regulation of plasma cholesterol esterification by sphingomyelin: effect of physiological variations of plasma sphingomyelin on lecithin-cholesterol acyltransferase activity.
Subbaiah PV; Jiang XC; Belikova NA; Aizezi B; Huang ZH; Reardon CA
Biochim Biophys Acta; 2012 Jun; 1821(6):908-13. PubMed ID: 22370449
[TBL] [Abstract][Full Text] [Related]
8. Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT.
Furbee JW; Francone O; Parks JS
J Lipid Res; 2001 Oct; 42(10):1626-35. PubMed ID: 11590219
[TBL] [Abstract][Full Text] [Related]
9. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
[TBL] [Abstract][Full Text] [Related]
10. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
[TBL] [Abstract][Full Text] [Related]
11. ACAT2 contributes cholesteryl esters to newly secreted VLDL, whereas LCAT adds cholesteryl ester to LDL in mice.
Lee RG; Shah R; Sawyer JK; Hamilton RL; Parks JS; Rudel LL
J Lipid Res; 2005 Jun; 46(6):1205-12. PubMed ID: 15805543
[TBL] [Abstract][Full Text] [Related]
12. Effective lowering of plasma, LDL, and esterified cholesterol in LDL receptor-knockout mice by adenovirus-mediated gene delivery of ApoB mRNA editing enzyme (Apobec1).
Teng B; Ishida B; Forte TM; Blumenthal S; Song LZ; Gotto AM; Chan L
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):889-97. PubMed ID: 9157952
[TBL] [Abstract][Full Text] [Related]
13. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice.
Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188
[TBL] [Abstract][Full Text] [Related]
14. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
[TBL] [Abstract][Full Text] [Related]
15. Plasma lecithin-cholesterol acyltransferase activity and plasma lipoprotein composition and concentrations in kwashiorkor.
Dhansay MA; Benadé AJ; Donald PR
Am J Clin Nutr; 1991 Feb; 53(2):512-9. PubMed ID: 1989419
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
[TBL] [Abstract][Full Text] [Related]
17. Novel missense variants in LCAT and APOB genes in an Italian kindred with familial lecithin:cholesterol acyltransferase deficiency and hypobetalipoproteinemia.
Conca P; Pileggi S; Simonelli S; Boer E; Boscutti G; Magnolo L; Tarugi P; Penco S; Franceschini G; Calabresi L; Gomaraschi M
J Clin Lipidol; 2012; 6(3):244-50. PubMed ID: 22658148
[TBL] [Abstract][Full Text] [Related]
18. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice.
Forte TM; Subbanagounder G; Berliner JA; Blanche PJ; Clermont AO; Jia Z; Oda MN; Krauss RM; Bielicki JK
J Lipid Res; 2002 Mar; 43(3):477-85. PubMed ID: 11893784
[TBL] [Abstract][Full Text] [Related]
19. AAV8-mediated long-term expression of human LCAT significantly improves lipid profiles in hCETP;Ldlr(+/-) mice.
Chen Z; Chu D; Castro-Perez JM; Ni W; Zhang A; Krsmanovic ML; Xie D; Shah V; Stout SJ; McLaren DG; Stefanni AC; Lee SH; Roddy TP; Plump AS; Hubbard BK; Vogt TF; Zhou HH
J Cardiovasc Transl Res; 2011 Dec; 4(6):801-10. PubMed ID: 21822774
[TBL] [Abstract][Full Text] [Related]
20. Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.
O K; Frohlich J
J Lipid Res; 1995 Nov; 36(11):2344-54. PubMed ID: 8656072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
